By K. Alok Pathak, Richard W. Nason
This quantity brings jointly the paintings of specialists from scientific and easy sciences specialties and addresses the various debatable concerns and advances within the administration of oral melanoma. bettering the result for the oral melanoma sufferer would require devoted paintings from many disciplines operating jointly as multidisciplinary devices. The ebook is intended for scientific scholars, citizens and experts in numerous disciplines, together with otolaryngology, head and neck surgical procedure, neurosurgery, cosmetic surgery, maxillofacial surgical procedure and oncology.
Read or Download Controversies in Oral Cancer PDF
Similar oncology books
The gastrointestinal song offers one of many unique platforms the place a number of malignancies, together with adenocarcinoma of the pancreas, esophagus and colon are each one linked to weight problems. This certain organization is roofed during this quantity of strength stability and melanoma from the epidemiologic, biologic and strength etiologic standpoint.
With an annual cost of greater than 12 million international diagnoses and seven. 6 million deaths, the societal and fiscal burden of melanoma can't be overstated. mind metastases are the commonest malignant tumors of the relevant fearful process, but their occurrence seems to be expanding despite the development of melanoma remedies.
This quantity develops effects on non-stop time branching techniques and applies them to check price of tumor development, extending vintage paintings at the Luria-Delbruck distribution. to that end, the writer calculate the chance that mutations that confer resistance to remedy are current at detection and quantify the level of tumor heterogeneity.
- WHO Classification of Tumours of hematopoietic and lymphoid tissues 4th edition
- Onconephrology: Cancer, Chemotherapy and the Kidney
- Urologic Oncology
- Deoxynucleoside Analogs in Cancer Therapy (Cancer Drug Discovery and Development)
- The Official Patient's Sourcebook on Penile Cancer: A Revised and Updated Directory for the Internet Age
- Breast Cancer: A Guide to Detection and Multidisciplinary Therapy
Additional resources for Controversies in Oral Cancer
Bozec A, Peyrade F, Fischel JL, et al. Emerging molecular targeted therapies in the treatment of head and neck cancer. Expert Opin Emerg Drugs 2009;14:299–310. 28. Dietz A, Boehm A, Mozet C, et al. Current aspects of targeted therapy in head and neck tumors. Eur Arch Otorhinolaryngol 2008;265:3–12. 29. Shirai K, O’Brien PE. Molecular targets in squamous cell carcinoma of the head and neck. Curr Treat Options Oncol 2007;8:239–51. 30. Langer CJ. Targeted therapy in head and neck cancer: State-of-the-art 2007 and review of clinical applications.
Jungell P, Konttinen YT, Nortamo P, et al. Immunoelectron microscopic study of distribution of T-cell subsets in oral lichen planus. Scand J Dent Res 1989;97:361–7. 48. Santoro A, Majorana A, Bardellini E, et al. NF-kappaB expression in oral and cutaneous lichen planus. J Pathol 2003;201:466–72. 49. Karatsaidis A, Schreurs O, Axell T, et al. Inhibition of the transforming growth factor-beta/ Smad signaling pathway in the epithelium of oral lichen. J Invest Dermatol 2003;121: 1283–90. 50. Farhi D, Dupin N.
Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck. Cancer 2009;115:2138–46. 65. Argiris A, Ghebremichael M, Gilbert J, et al. A phase III randomized, placebo-controlled trial of docetaxel (D) with or without gefitinib (G) in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): A trial of the Eastern Cooperative Oncology Group (ECOG). J Clin Oncol 2009;27(Suppl):5 s (abstract 6011).